TCRT - Latest News

Alaunos Therapeutics, Inc. (TCRT), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $5.9M. Beta to the broader market is -1.13.

The article list below shows the most recent TCRT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent TCRT Headlines

Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies

globenewswire.com - May 26, 2026

ALN1003 demonstrated consistent, favorable effects across key drivers of metabolic disease, including reductions in body weight and fat mass, improved

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

globenewswire.com - May 18, 2026

FORT LAUDERDALE, Fla. , May 18, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc.

Valion Bio Appoints Melinda Lackey as General Counsel

prnewswire.com - May 4, 2026

/PRNewswire/ -- Valion Bio, Inc. (formerly Tivic Health Systems, Inc.

Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop

benzinga.com - Mar 2, 2026

Alaunos Therapeutics Inc. (NASDAQ: TCRT) shares are down on Monday after the company announced preclinical proof-of-concept data for its lead drug ca

Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

globenewswire.com - Mar 2, 2026

Alaunos' ALN1003 shows dose dependent weight loss, better body composition, reduced liver weight, and improved liver biomarkers in preclinical studies

How News Affects TCRT Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TCRT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked TCRT news questions

What is the latest TCRT news headline?

The most recent TCRT headline (May 26, 2026) is "Alaunos Reports Broad Metabolic Improvements with ALN1003 in Obese Mouse Studies". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the TCRT news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What TCRT news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual TCRT options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.